Effect of ranolazine on ventricular repolarization in class III antiarrhythmic drug-treated rabbits

被引:33
作者
Frommeyer, Gerrit [1 ]
Kaiser, Dennis [1 ]
Uphaus, Timo [1 ]
Kaese, Sven [1 ]
Osada, Nani [2 ]
Rajamani, Sridharan [3 ]
Belardinelli, Luiz [3 ]
Breithardt, Guenter [1 ]
Eckardt, Lars [1 ]
Milberg, Peter [1 ]
机构
[1] Univ Munster, Dept Cardiovasc Med, Div Electrophysiol, Munster, Germany
[2] Univ Munster, Dept Med Informat & Biomath, Munster, Germany
[3] Gilead Sci Inc, Dept Biol, Foster City, CA 94404 USA
关键词
Ranolazine; Amiodarone; Dronedarone; Postrepolarization refractoriness; Dispersion of repolarization; Proarrhythmia; Repolarization reserve; ACTION-POTENTIAL DURATION; DE-POINTES ARRHYTHMIAS; LATE NA+ CURRENT; ATRIAL-FIBRILLATION; POSTREPOLARIZATION REFRACTORINESS; D-SOTALOL; EARLY AFTERDEPOLARIZATIONS; CHRONIC AMIODARONE; ANTIANGINAL AGENT; CHRONIC ANGINA;
D O I
10.1016/j.hrthm.2012.08.029
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND Ranolazine exhibits a synergistic effect in combination with class III drugs to suppress atrial fibrillation. OBJECTIVE To investigate whether a combination therapy affects repolarization and provokes ventricular tachyarrhythmias (VT) in a sensitive model of proarrhythmia. METHODS Thirty-seven rabbits were assigned to 3 groups and fed with amiodarone (50 mg/kg/d; n = 10) or dronedarone (50 mg/kg/d; n = 10) over a period of 6 weeks. A third group was used as control (n = 17). After obtaining baseline data in Langendorff-perfused control hearts, sotalol (100 mu M) was administered in this group. Thereafter, ranolazine (10 mu M) was additionally infused on top of amiodarone, dronedarone, or sotalol. RESULTS Chronic treatment with amiodarone or dronedarone as well as sotalol significantly increased action potential duration at 90% repolarization (APD(90)). Additional treatment with ranolazine further increased APD(90) in amiodarone- and dronedarone-pretreated hearts but not in sotalol-treated hearts. Ranolazine increased postrepolarization refractoriness as compared with amiodarone or dronedarone alone owing to a marked effect on the refractory period. In contrast to amiodarone and dronedarone, acute application of sotalol increased dispersion of repolarization (P < .05). Additional treatment with ranolazine did not further increase spatial or temporal dispersion. After lowering extracellular [K+] in bradycardic hearts, no proarrhythmia occurred in amiodarone- or dronedarone-treated hearts whereas 11 of 17 sotalol treated hearts showed early after depolarizations and subsequent polymorphic VT. Additional treatment with ranolazine reduced the number of VT episodes in sotalol-treated hearts and did not cause proarrhythmia in combination with amiodarone or dronedarone. CONCLUSIONS Application of ranolazine on top of class III drugs does not cause proarrhythmia despite a marked effect on ventricular repolarization. The effect of ranolazine on the repolarization reserve is associated with the lack of effect on early afterdepolarizations and dispersion of repolarization.
引用
收藏
页码:2051 / 2058
页数:8
相关论文
共 41 条
[1]   Late Na+ Current Inhibition by Ranolazine Reduces Torsades de Pointes in the Chronic Atrioventricular Block Dog Model [J].
Antoons, Gudrun ;
Oros, Avram ;
Beekman, Jet D. M. ;
Engelen, Markus A. ;
Houtman, Marien J. C. ;
Belardinelli, Luiz ;
Stengl, Milan ;
Vos, Marc A. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (08) :801-809
[2]   Electrophysiological effects of ranolazine, a novel antianginal agent with antiarrhythmic properties [J].
Antzelevitch, C ;
Belardinelli, L ;
Zygmunt, AC ;
Burashnikov, A ;
Di Diego, JM ;
Fish, JM ;
Cordeiro, JM ;
Thomas, G .
CIRCULATION, 2004, 110 (08) :904-910
[3]   Electrophysiologic basis for the antiarrhythmic actions of ranolazine [J].
Antzelevitch, Charles ;
Burashnikov, Alexander ;
Sicouri, Serge ;
Belardinelli, Luiz .
HEART RHYTHM, 2011, 8 (08) :1281-1290
[4]   Ranolazine Reduces Ventricular Tachycardia Burden and ICD Shocks in Patients with Drug-Refractory ICD Shocks [J].
Bunch, T. Jared ;
Mahapatra, Srijoy ;
Murdock, David ;
Molden, Jamie ;
Weiss, J. Peter ;
May, Heidi T. ;
Bair, Tami L. ;
Mader, Katy M. ;
Crandall, Brian G. ;
Day, John D. ;
Osborn, Jeffrey S. ;
Muhlestein, Joseph B. ;
Lappe, Donald L. ;
Anderson, Jeffrey L. .
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2011, 34 (12) :1600-1606
[5]   Atrium-selective sodium channel block as a strategy for suppression of atrial fibrillation - Differences in sodium channel inactivation between atria and ventricles and the role of ranolazine [J].
Burashnikov, Alexander ;
Di Diego, Jose M. ;
Zygmunt, Andrew C. ;
Belardinelli, Luiz ;
Antzelevitch, Charles .
CIRCULATION, 2007, 116 (13) :1449-1457
[6]   Synergistic Effect of the Combination of Ranolazine and Dronedarone to Suppress Atrial Fibrillation [J].
Burashnikov, Alexander ;
Sicouri, Serge ;
Di Diego, Jose M. ;
Belardinelli, Luiz ;
Antzelevitch, Charles .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 56 (15) :1216-1224
[7]   Myocardial amiodarone concentrations after short- and long-term treatment in patients with end-stage heart failure [J].
Candinas, R ;
Frielingsdorf, J ;
Ha, HR ;
Carrel, T ;
Turina, M ;
Follath, F .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 53 (05) :331-336
[8]   Ranolazine for the treatment of chronic angina and potential use in other cardiovascular conditions [J].
Chaitman, Bernard R. .
CIRCULATION, 2006, 113 (20) :2462-2472
[9]   Ranolazine, an antianginal agent, markedly reduces ventricular arrhythmias induced by ischemia and ischemia-reperfusion [J].
Dhalla, Arvinder K. ;
Wang, Wei-Qun ;
Dow, Joan ;
Shryock, John C. ;
Belardinelli, Luiz ;
Bhandari, Anil ;
Kloner, Robert A. .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2009, 297 (05) :H1923-H1929
[10]   Molecular basis of ranolazine block of LQT-3 mutant sodium channels: evidence for site of action [J].
Fredj, Sandra ;
Sampson, Kevin J. ;
Liu, Huajun ;
Kass, Robert S. .
BRITISH JOURNAL OF PHARMACOLOGY, 2006, 148 (01) :16-24